Circassia Group (CIR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

30.00p
   
  • Change Today:
      0.65p
  • 52 Week High: 32.00
  • 52 Week Low: 12.93
  • Currency: UK Pounds
  • Shares Issued: 397.48m
  • Volume: 91,943
  • Market Cap: £119.25m
  • RiskGrade: 7

FTSE 250 movers: Dead cat bounce in Circassia

By Alexander Bueso

Date: Tuesday 21 Jun 2016

LONDON (ShareCast) - (ShareCast News) - High-tech components manufacturer Senior led the fallers on the mid-cap index after it issued a pre-close trading update on Tuesday, in which it reiterated that margins in the aerospace division will be lower in the first half of 2016.
The FTSE 250 firm said activity in aerospace is anticipated to increase during the period in line with expectations, but margins will be lower as the ramp-up of new production programmes continues.

Bank of America Merrill Lynch upgraded ICAP to 'buy' from 'neutral' with an unchanged price target of 500p, saying the stock's recent underperformance has added valuation appeal to a compelling strategy.

It noted ICAP shares have dropped 19% this year, which is around 18% more than the All Share and attributed much of the weakness to macro/referendum concerns.

The bank said it continues to see ICAP as well placed, especially post the NEX separation. NEX is the company which will endure once ICAP sells the bulk of its voice assets to Tullett Prebon.

Shares in biopharmaceutical development company Circassia Pharmaceuticals bounced back after the previous day's plunge after it announced disappointing top-line results from its investigational cat allergy immunotherapy phase III study.

Analysts at RBC Capital Markets said while the Cat-SPIRE PIII results were disappointing, the implications for the rest of the SPIREs remain in the balance until a better understanding of trial results emerged.

"At 250p of option value it could be tempting to buy ahead of the event but we downgrade to 'sector perform' from 'top pick' until more is known on how to progress and fund these assets through the clinic."



FTSE 250 - Risers

Circassia Pharmaceuticals (CIR) 97.00p 6.59%
Softcat (SCT) 360.10p 5.73%
Allied Minds (ALM) 358.30p 5.38%
Evraz (EVR) 129.10p 4.96%
Hansteen Holdings (HSTN) 107.00p 4.39%
ICAP (IAP) 430.10p 3.76%
NMC Health (NMC) 1,187.00p 3.22%
F&C Commercial Property Trust Ltd. (FCPT) 123.50p 3.00%
Telecom Plus (TEP) 1,032.00p 2.99%
Ocado Group (OCDO) 244.90p 2.98%

FTSE 250 - Fallers

Senior (SNR) 196.70p -12.78%
Cairn Energy (CNE) 189.70p -5.06%
IMI (IMI) 969.50p -3.91%
Kaz Minerals (KAZ) 134.50p -3.72%
Centamin (DI) (CEY) 106.30p -3.63%
Entertainment One Limited (ETO) 172.40p -3.20%
Wetherspoon (J.D.) (JDW) 719.50p -3.16%
BGEO Group (BGEO) 2,549.00p -2.75%
Genus (GNS) 1,559.00p -2.74%
Fidessa Group (FDSA) 2,214.00p -2.60%

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CIR Market Data

Currency UK Pounds
Share Price 30.00p
Change Today 0.65p
% Change 2.21 %
52 Week High 32.00
52 Week Low 12.93
Volume 91,943
Shares Issued 397.48m
Market Cap £119.25m
RiskGrade 7

CIR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.11% below the market average5.11% below the market average5.11% below the market average5.11% below the market average5.11% below the market average
85.19% above the sector average85.19% above the sector average85.19% above the sector average85.19% above the sector average85.19% above the sector average
Price Trend
27.86% above the market average27.86% above the market average27.86% above the market average27.86% above the market average27.86% above the market average
10.34% below the sector average10.34% below the sector average10.34% below the sector average10.34% below the sector average10.34% below the sector average
Income Not Available
Growth
42.62% above the market average42.62% above the market average42.62% above the market average42.62% above the market average42.62% above the market average
18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 0
Sell 0
Strong Sell 1
Total 1
strong_sell
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CIR Dividends

No dividends found

Trades for 30-Nov-2020

Time Volume / Share Price
16:35 273 @ 30.00p
16:26 1,073 @ 29.40p
16:24 855 @ 29.40p
16:13 993 @ 29.40p
16:01 18 @ 29.06p

Top of Page